Sanofi SNY
NASDAQ SNY
$40.97 -0.26 (-0.62%)
As of: Oct 1, 2026 · 12:18 PM EDT

Sanofi (SNY) Convertible Debt (2019 - 2021)

Updated

Sanofi's Convertible Debt was $223.07 million in the quarter ended Dec 31, 2021, down 14.8% from $261.83 million a year earlier.

Analysis

Sanofi (SNY) Convertible Debt (2019 - 2021) Analysis & Trends

As of Dec 31, 2021, Convertible Debt at Sanofi came in at $230.76 million, down 8.0% from the prior year.

  • In earlier years, Convertible Debt was $250.73 million in the year ended Dec 31, 2020 (+2.8%) and $243.92 million in the year ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Sanofi 50.28 Bn 17.06 Bn 10.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 223.07 Mn
Dec 31, 2020 261.83 Mn
Dec 31, 2019 241.08 Mn
API Access

Sanofi Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=SNY&period=max&api_key=YOUR_API_KEY